In contrast, AAV‐mediated SFRP5 overexpression significantly improves left ventricular function and reduces hypertrophy by suppressing cardiac fibrosis, partially via AMPK pathway activation in the MI mouse model [262]. This evidence concerns the gene SFRP5 and myocardial infarction.